Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, Adult, antibodies, apoptosis, Diseases, Non-Biological, Combinations, Therapies, checkpoint inhibitors, Biological Processes, Technology and Procedures, Plasma Cell Disorders, immunotherapy, cytogenetics, Lymphoid Malignancies, Study Population, Clinically relevant, pathways
Type: Oral
Hematology Disease Topics & Pathways:
multiple myeloma, Biological, Adult, antibodies, apoptosis, Diseases, Non-Biological, Combinations, Therapies, checkpoint inhibitors, Biological Processes, Technology and Procedures, Plasma Cell Disorders, immunotherapy, cytogenetics, Lymphoid Malignancies, Study Population, Clinically relevant, pathways
Saturday, December 5, 2020: 2:00 PM-3:30 PM
Moderators:
Prashant Kapoor, MD, Mayo Clinic
and
Nina Shah, MD, University of California San Francisco
Disclosures:
Shah: BMS, Janssen, Bluebird Bio, Sutro Biopharma, Teneobio, Poseida, Nektar: Research Funding; GSK, Amgen, Indapta Therapeutics, Sanofi, BMS, CareDx, Kite, Karyopharm: Consultancy.
2:00 PM
2:15 PM
2:30 PM
2:45 PM
3:00 PM
3:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH